Neuberger Berman Group’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $4.18M | Sell |
|
|||||
|
2025
Q2 | $4.01M | Sell |
|
|||||
|
2025
Q1 | $7.22M | Buy |
|
|||||
|
2024
Q4 | $5.25M | Sell |
|
|||||
|
2024
Q3 | $5.94M | Buy |
|
|||||
|
2024
Q2 | $4.13M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $24.6M | Buy |
|
|||||
|
2020
Q4 | $21.8M | Buy |
|
|||||
|
2020
Q3 | $19.8M | Buy |
|
|||||
|
2020
Q2 | $15.7M | Buy |
|
|||||
|
2020
Q1 | $6.7M | Sell |
|
|||||
|
2019
Q4 | $9M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $916K | Buy |
|